Suzhou Basecare Medical Corporation Limited

SEHK:2170 Rapporto sulle azioni

Cap. di mercato: HK$908.1m

Suzhou Basecare Medical Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Bo Liang

Amministratore delegato

CN¥3.0m

Compenso totale

Percentuale dello stipendio del CEO84.4%
Mandato del CEO13.9yrs
Proprietà del CEOn/a
Durata media del management6.2yrs
Durata media del Consiglio di amministrazione2.6yrs

Aggiornamenti recenti sulla gestione

Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

May 30
Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

Recent updates

Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Nov 18
Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S

Sep 27
Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S

Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

May 30
Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet

Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story

May 09
Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story

Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch

Mar 22
Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch

Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?

Aug 01
Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?

Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop

May 26
Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop

Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?

Jul 20
Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Bo Liang rispetto agli utili di Suzhou Basecare Medical?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-CN¥250m

Mar 31 2024n/an/a

-CN¥221m

Dec 31 2023CN¥3mCN¥3m

-CN¥192m

Sep 30 2023n/an/a

-CN¥176m

Jun 30 2023n/an/a

-CN¥160m

Mar 31 2023n/an/a

-CN¥146m

Dec 31 2022CN¥3mCN¥3m

-CN¥132m

Sep 30 2022n/an/a

-CN¥133m

Jun 30 2022n/an/a

-CN¥135m

Mar 31 2022n/an/a

-CN¥139m

Dec 31 2021CN¥4mCN¥3m

-CN¥144m

Sep 30 2021n/an/a

-CN¥119m

Jun 30 2021n/an/a

-CN¥106m

Mar 31 2021n/an/a

-CN¥490m

Dec 31 2020CN¥8mCN¥1m

-CN¥874m

Sep 30 2020n/an/a

-CN¥1b

Jun 30 2020n/an/a

-CN¥1b

Mar 31 2020n/an/a

-CN¥822m

Dec 31 2019CN¥732kCN¥602k

-CN¥528m

Compensazione vs Mercato: La retribuzione totale di Bo ($USD 420.86K ) è superiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 233.47K ).

Compensazione vs guadagni: La retribuzione di Bo è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Bo Liang (43 yo)

13.9yrs

Mandato

CN¥3,046,000

Compensazione

Dr. Bo Liang serves as Executive Director and General Manager at Suzhou Basecare Medical Corporation Limited since December 14, 2010 and serves as its Chairman of the Board since December 14, 2015. Dr. Lia...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Bo Liang
Chairman of the Board & GM13.9yrsCN¥3.05mNessun dato
Lingyin Kong
CTO & Executive Director10.5yrsCN¥1.40mNessun dato
Ying Yang
Chief Quality Officer6.2yrsCN¥677.00kNessun dato
Lejun Yin
CFO & Joint Company Secretary2yrsNessun datoNessun dato
Maoshe Rui
Chief Operating Officer7.4yrsCN¥306.00kNessun dato
Junchao Jiang
Executive Directorless than a yearNessun datoNessun dato
Ming Fai Chung
Joint Company Secretary2.3yrsNessun datoNessun dato

6.2yrs

Durata media

43yo

Età media

Gestione esperta: Il team dirigenziale di 2170 è esperto e expertise (durata media dell'incarico 6.2 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Bo Liang
Chairman of the Board & GM13.9yrsCN¥3.05mNessun dato
Lingyin Kong
CTO & Executive Director8.4yrsCN¥1.40mNessun dato
Junchao Jiang
Executive Directorless than a yearNessun datoNessun dato
Xixiong Kang
Independent Non-Executive Director3.8yrsCN¥180.00kNessun dato
Wenbo Xu
Non-Executive Director6yrsNessun datoNessun dato
Weipeng Wang
Non-Executive Director8.2yrsNessun datoNessun dato
Yi Lin
Supervisor4.3yrsNessun datoNessun dato
Siu Wing Lam
Independent Non-Executive Director1.3yrsCN¥84.00kNessun dato
Shu Biu Yeung
Independent Non-executive Director1.3yrsCN¥70.00kNessun dato
Yang Ling
Non-executive Director1.3yrsNessun datoNessun dato
Lijuan Shi
Chairwoman of the Supervisory Board1.3yrsNessun datoNessun dato
Qiuping Zong
Supervisor1.3yrsNessun datoNessun dato

2.6yrs

Durata media

43yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 2170 non è considerato esperto (durata media del mandato 2.6 anni), il che suggerisce un nuovo consiglio.